New gene therapy cures 1st New Yorker of sickle cell anemia

Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle cell anemia.
Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy.
Long Island patient gets breakthrough sickle cell treatment called a ‘cure’: ‘I’m not in pain anymore’
He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and successfully wiped away sickle cell disease from a Laurelton man. Cohen Children’s Medical Center said patient Sebastien Beauzile,
Man makes history by becoming the first in New York to be cured of sickle cell anemia, doctors say
A Long Island hospital has said that it has successfully eliminated sickle cell disease from Sebastien Beauzile, a 21-year-old from Laurelton, using the groundbreaking Lyfgenia gene therapy. Cohen Children’s Medical Center confirmed Beauzile as the first New Yorker to receive this life-changing treatment,
Gene therapy cures man from sickle cell
A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life. He was Sebastien Beauzile was born with sickle cell anemia and struggled to live a pain free life. However,
Sickle cell gene therapy frees teen from life of pain
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
‘I’m Unstoppable’: New gene therapy cures first New Yorker of sickle cell anemia
Twenty-one-year-old Sebastien Beauzile was all smiles as he was serenaded with “Happy Birthday” on what he calls his new birthday at Cohen Children’s Medical
CASGEVY: NHS Approves First Sickle Cell Gene Therapy
Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic editing technique.
'Common disease took my sight and ate my body - it takes 130 people to keep me alive'
Amid a genetic breakthrough in the treatment of sickle cell disease, The Mirror investigates the agonising reality of living ...
News-Medical.Net on MSN2d
CRISPR technologies paving the way for advances in regenerative medicine
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...
The Daily Targum2d
Rutgers Cancer Institute receives gene therapy treatment center designation
The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...